Sex differences in the clinical manifestations of Alzheimer disease pathology - PubMed (original) (raw)
Sex differences in the clinical manifestations of Alzheimer disease pathology
Lisa L Barnes et al. Arch Gen Psychiatry. 2005 Jun.
Abstract
Context: Sex differences in risk of clinically diagnosed Alzheimer disease (AD) have been studied extensively, but little is known about the relation of the pathologic indices of AD to the clinical manifestations of the disease in men compared with women.
Objective: To test whether the relation of AD pathology to the clinical manifestations of the disease differs in men and women.
Design: Longitudinal, clinicopathologic cohort study.
Participants and setting: Analyses were conducted on 141 older Catholic clergy members who underwent detailed annual clinical evaluations and brain autopsy at death. The number of neuritic plaques, diffuse plaques, and neurofibrillary tangles in a 1-mm2 area sampled from 4 cortical regions was counted, and a global measure of AD pathology (range, 0-2.98 U) and specific measures of each pathology were derived.
Main outcome measures: Clinical diagnosis of probable AD and level of global cognitive function at the last evaluation before death.
Results: Women had more global AD pathology than did men (P = .04), due primarily to more neurofibrillary tangles (P = .02). At the last evaluation before death, 57 persons met clinical criteria for probable AD (34 [60%] of them women). In logistic regression models, sex was not related to odds of clinical AD (odds ratio [OR], 1.35; 95% confidence interval [CI], 0.56-3.25), but the relation of global AD pathology to clinical diagnosis differed for men and women. Each additional unit of AD pathology was associated with a nearly 3-fold increase in the odds of clinical AD in men (OR, 2.82; 95% CI, 1.03-7.65) compared with a more than 20-fold increase in the odds of clinical AD in women (OR, 22.67; 95% CI, 5.11-100.53). Results were unchanged after controlling for potential confounders or using level of cognition as the outcome.
Conclusion: These data suggest that AD pathology is more likely to be clinically expressed as dementia in women than in men.
Similar articles
- Diabetes is related to cerebral infarction but not to AD pathology in older persons.
Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, Bennett DA. Arvanitakis Z, et al. Neurology. 2006 Dec 12;67(11):1960-5. doi: 10.1212/01.wnl.0000247053.45483.4e. Neurology. 2006. PMID: 17159101 - Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Bennett DA, et al. Arch Neurol. 2004 Mar;61(3):378-84. doi: 10.1001/archneur.61.3.378. Arch Neurol. 2004. PMID: 15023815 - APOE, vascular pathology, and the AD brain.
Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, Farrer LA. Yip AG, et al. Neurology. 2005 Jul 26;65(2):259-65. doi: 10.1212/01.wnl.0000168863.49053.4d. Neurology. 2005. PMID: 16043796 - [Neuropathology of Alzheimer's disease and mild cognitive impairment].
López OL, DeKosky ST. López OL, et al. Rev Neurol. 2003 Jul 16-31;37(2):155-63. Rev Neurol. 2003. PMID: 12938076 Review. Spanish. - Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.
Ferrer I. Ferrer I. Prog Neurobiol. 2012 Apr;97(1):38-51. doi: 10.1016/j.pneurobio.2012.03.005. Epub 2012 Mar 21. Prog Neurobiol. 2012. PMID: 22459297 Review.
Cited by
- Opposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218/PTPA pathway.
Xiong YS, Liu FF, Liu D, Huang HZ, Wei N, Tan L, Chen JG, Man HY, Gong CX, Lu Y, Wang JZ, Zhu LQ. Xiong YS, et al. Aging Cell. 2015 Oct;14(5):867-77. doi: 10.1111/acel.12366. Epub 2015 Jun 26. Aging Cell. 2015. PMID: 26111662 Free PMC article. - Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.
Edwards L, La Joie R, Iaccarino L, Strom A, Baker SL, Casaletto KB, Cobigo Y, Grant H, Kim M, Kramer JH, Mellinger TJ, Pham J, Possin KL, Rosen HJ, Soleimani-Meigooni DN, Wolf A, Miller BL, Rabinovici GD. Edwards L, et al. Neurobiol Aging. 2021 Sep;105:86-98. doi: 10.1016/j.neurobiolaging.2021.04.003. Epub 2021 Apr 22. Neurobiol Aging. 2021. PMID: 34049062 Free PMC article. - Intra-individual reaction time variability in mild cognitive impairment and Alzheimer's disease: gender, processing load and speed factors.
Phillips M, Rogers P, Haworth J, Bayer A, Tales A. Phillips M, et al. PLoS One. 2013 Jun 10;8(6):e65712. doi: 10.1371/journal.pone.0065712. Print 2013. PLoS One. 2013. PMID: 23762413 Free PMC article. - Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
Hanna Al-Shaikh FS, Duara R, Crook JE, Lesser ER, Schaeverbeke J, Hinkle KM, Ross OA, Ertekin-Taner N, Pedraza O, Dickson DW, Graff-Radford NR, Murray ME. Hanna Al-Shaikh FS, et al. JAMA Neurol. 2020 Feb 1;77(2):225-233. doi: 10.1001/jamaneurol.2019.3606. JAMA Neurol. 2020. PMID: 31657834 Free PMC article. - The Role of Sex and Sex Hormones in Neurodegenerative Diseases.
Vegeto E, Villa A, Della Torre S, Crippa V, Rusmini P, Cristofani R, Galbiati M, Maggi A, Poletti A. Vegeto E, et al. Endocr Rev. 2020 Apr 1;41(2):273-319. doi: 10.1210/endrev/bnz005. Endocr Rev. 2020. PMID: 31544208 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous